PRIMARY STUDY
The endocannabinoid system - a target for the treatment of LUTS?
Key Findings: Currently, the endocannabinoid system is considered as a potential drug target for pharmacological management of LUTS, with a more favourable adverse event profile than antimuscarinic agents.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Germany, Sweden
Year of Pub: 2016
Cannabinoids Studied: Cannabinoid (unspecified), Endocannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
